series-a
Stage
1
Investors
About
Precision NanoSystems develops instruments and reagent kits for the formulation and scalable manufacturing of nanoparticle and lipid nanoparticle-based drug delivery systems, enabling development of nucleic acid therapeutics. Its NanoAssemblr platform provides controlled mixing technologies used by biotech and pharma to produce lipid nanoparticles for mRNA and other payloads.
Explore Precision NanoSystems's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.